CK2 is a pleiotropic, ubiquitous, and constitutively active protein kinase (PK), with both cytosolic and nuclear localization in most mammalian cells. The holoenzyme is generally composed of two catalytic (alpha and/or alpha') and two regulatory (beta) subunits, but the free alpha/alpha' subunits ar
ChemInform Abstract: How Druggable Is Protein Kinase CK2?
β Scribed by Giorgio Cozza; Andrea Bortolato; Stefano Moro
- Publisher
- John Wiley and Sons
- Year
- 2010
- Weight
- 15 KB
- Volume
- 41
- Category
- Article
- ISSN
- 0931-7597
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract Review: 168 refs.
## Abstract Increasing evidence points to a link between histone deacetylases (HDACs) and tumorigenesis. Although several HDAC inhibitors have been tested in clinical trials for cancer therapies, the mechanisms of HDAC activation in tumors remain unknown. In this study, we investigated the pathway
## Abstract The protein kinase CK2 is constituted by two catalytic (Ξ± and/or Ξ±β²) and two regulatory (Ξ²) subunits. CK2 phosphorylates more than 300 proteins with important functions in the cell cycle. This study has looked at the relation between CK2 and p27^KIP1^, which is a regulator of the cell c